Differences in E-lung Biomarker Scores Between Treatment Groups in Post-hoc Analysis of the ATLAS Inhaled Pirfenidone Solution (AP01) for IPF Clinical Trial

P.M. George,C. Rennison-Jones, F. Ottink,F.A. Woodhead, W. Abou-Zeid,O. Joly,D. Nair, A. Sifostratoudaki, R. Stewart, C. Fernandez, H.M. Lazarus,S. Gerry,G. Harston,A. Devaraj

B48 NEW TREATMENTS IN DIFFUSE PARENCHYMAL LUNG DISEASE（2024）

引用 0|浏览8

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要